| Sector |
Finance
|
Compare with Sector peers |
| Industry |
Finance - Investment
|
Compare with Industry peers |
| Website | http://www.shalimaragenciesltd.com | |
| Market Cap | 13.31 Cr. | |
| Enterprise Value(EV) | Cr. | - |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -0.25 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 21.92 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 9.62 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 4.61 | Calculated using Price: 44.36 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.30 Cr. | 3,001,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Shalimar Agencies is engaged in distribution of pharmaceutical formulations for Healthcare goods. | ||
| 1 Day |
|
|
| 1 Week |
|
+4.99% |
| 1 Month |
|
+4.99% |
| 3 Month |
|
+15.67% |
| 6 Month |
|
+27.29% |
| 1 Year |
|
+61.90% |
| 2 Year |
|
+280.77% |
| 5 Year |
|
+294.31% |
| 10 Year |
|
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 0.32 | 0.68 | 0.59 | -5.00 | -4.97 | -2.51 | -2.93 | -2.98 | -3.57 | |
| Return on Capital Employed (%) | 0.51 | 0.85 | 0.86 | -4.99 | -4.95 | -2.51 | -2.94 | -2.97 | -3.55 | |
| Return on Assets (%) | 0.31 | 0.67 | 0.58 | -4.89 | -4.90 | -2.49 | -2.86 | -2.83 | -3.28 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 1 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |
| Non Curr. Liab. | |||||||||||
| Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 1 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | |
| Non Curr. Assets | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | ||
| Curr. Assets | 1 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 1 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 1 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 4 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 0 | 0 | 0 | 9 | 10 | 1 | |||||
| Other Income | 0 | 0 | 0 | 0 | 0 | ||||||
| Total Income | 0 | 0 | 1 | 9 | 11 | 1 | |||||
| Total Expenditure | 0 | 0 | 0 | -10 | -11 | -2 | 0 | 0 | 0 | 0 | |
| PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest | |||||||||||
| Depreciation | 0 | 0 | |||||||||
| Taxation | 0 | ||||||||||
| Exceptional Items | |||||||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Adjusted EPS | 0 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 | 0 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | -2 | 0 | -1 | 0 | 1 | 0 | 0 | ||
| Cash Fr. Inv. | 0 | 0 | 0 | 0 | 1 | 0 | -1 | 0 | |||
| Cash Fr. Finan. | 2 | ||||||||||
| Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
|
Mon, 13 Feb 2023
Submission Of Un-Audited Financial Results Of The Company U/R 33 Of SEBI (LODR) Regulations 2015 For The 3Rd Quarter Ended 31St December 2022 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 The Board of Directors of the Company in their meeting held on Monday the 13th of February 2023 inter-alia have discussed and approved Unaudited Financial Results and Limited Review Report of the Company for the 3rd Quarter ended 31st December 2022. |
|
Mon, 30 Jan 2023
Board Meeting Intimation for Notice Of Board Meeting & Intimation U/R 29(1) Of SEBI (LODR) Regulations Shalimar Agencies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 information is hereby given that a Meeting of the Board of Directors of the Company will be held on Monday the 13th February 2023 at 04: 00 PM at the Registered Office inter-alia to consider and approve Unaudited Financial Results for the 3rd Quarter ended 31st December 2022. |
|
Fri, 13 Jan 2023
Announcement under Regulation 30 (LODR)-Change in Directorate Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Para A of Part A of Schedule III to the Listing Regulations we wish to inform that Mr. Manoj Sandilya Telakapalli (DIN: 09630299) has stepped down from the position of the Whole Time Director of the Company with effect from today i.e. 12-01-2023. However He continues to be on the Board of the Company as Director of the Company.Further the Company has received confirmation from aforementioned Director that there are no material reasons for his Change in Designation other than those mentioned in his resignation letter dated 12-01-2023 |
| Mon, 20 Mar 2023 |
Close Crossing Last Week High
|
Close Crossing Last Month High
|
Close Crossing Last Month Close From Below
|
Close Crossing 52 Week High
|
Opening at High
|
Equities
M.F.
Sectors